Stephanie Reuter Lange

Research Interests

Clinical Pharmacology and Therapeutics Clinical Trials

Teaching Strengths

Physiology
Pharmacology
Pharmacokinetics
Biostatistics

Prof Stephanie Reuter Lange

Professor of Clinical Pharmacology

School of Pharmacy and Biomedical Sciences

College of Health

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Available For Media Comment.

As a Professor in Clinical Pharmacology, Stephanie Reuter Lange’s research portfolio broadly focusses on using scientific principles to inform the optimal use of medications. Appropriately, through this activity she works extensively with pharmaceutical industry and regulatory agencies in the development of new drug entities, as well as clinicians and pharmacists to improve the use of existing drugs for better management of patients in clinical practice. Her research philosophy is one of translation, specifically bridging the interface between foundational science and clinical practice, acting as a conduit between science, policy and the clinic.

Stephanie currently holds Cancer Council Mid-Career Fellowship, which aims to address the medication issues associated with the sub-optimal use of anti-cancer agents and develop rational, evidence-based guidelines for the appropriate prescription of these drugs in clinical practice. She has previously been awarded a prestigious Fulbright Visiting Research Scholarship to undertake research with world leaders in the field of PK/PD modelling at the State University of New York, using innovative techniques to inform the quality use of medicines.

Date Type Title Institution Name Country Amount
2022 Award APSA Medal Australasian Pharmaceutical Science Association Australia -
2020 Fellowship Beat Cancer Mid-Career Fellowship Cancer Council Australia Australia -
2020 Award Certara New Investigator Award Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists Australia -
2018 Award UniSA Research Excellence Award – Early Career Researcher University of South Australia Australia -
2014 Award Tall Poppy Award Australian Institute of Policy and Science Australia -
2014 Award SA Science Excellence Award – People’s Choice Government of South Australia Australia -
2013 Fellowship HMRc Australian Clinical Fellowship National Health and Medical Research Council Australia -
2012 Fellowship Fulbright Postdoctoral Research Scholarship Australian-American Fulbright Commission United States -
2012 Award SA Science Excellence Award – PhD Research Excellence Government of South Australia Australia -
2012 Award Postgraduate Medal University of South Australia Australia -

Date Institution name Country Title
2004 - 2011 University of South Australia Australia Doctor of Philosophy
1999 - 1999 University of Adelaide Australia Bachelor of Science (Honours)
1996 - 1998 University of Adelaide Australia Bachelor of Science

Year Citation
2025 Tan, M. S., Patel, B. K., Roughead, E. E., Ward, M., Reuter, S. E., Roberts, G., & Andrade, A. Q. (2025). Opportunities for clinical decision support targeting medication safety in remote primary care management of chronic kidney disease: a qualitative study in Northern Australia. Journal of Telemedicine and Telecare, 31(5), 656-666.
DOI Scopus2 WoS1 Europe PMC1
2025 Malouh, M. A., Cichero, J. A. Y., Reuter, S. E., Weng, M. T., Lau, E. T. L., Nissen, L. M., & Steadman, K. J. (2025). Does using oral medication lubricants to swallow whole or crushed tablets alter drug absorption in vivo? A randomised, single-dose crossover bioequivalence study in healthy adults. Journal of Drug Delivery Science and Technology, 104, 1-8.
DOI Scopus2 WoS2
2025 Reuter, S. E., Schultz, H. B., Mclachlan, A. J., Henson, J. D., & Vitetta, L. (2025). Pharmacokinetics and bioavailability of cannabinoids administered via a novel orobuccal nanoparticle formulation (NanoCelle™) in patients with advanced cancer. Cannabis and Cannabinoid Research, online(6), 1-11.
DOI Scopus1 WoS2
2025 Meola, T. R., Ludbrook, G., Fornasini, G., Pavlova, O., Jain, S., Evans, A. M., & Reuter, S. E. (2025). Absolute bioavailability and intravenous pharmacokinetics of N-acetyl-D-mannosamine in humans. British Journal of Clinical Pharmacology, online(2), 1-7.
DOI Europe PMC1
2025 Wong, S., Selby, P. R., Ward, M. B., & Reuter, S. E. (2025). Exploring health care professionals' engagement with a precision dosing calculator and supporting clinical information: insights from an eye-tracking and usability study. Therapeutic Drug Monitoring, online(6), 1-10.
DOI
2024 Larcombe, R., Coulthard, K., Eaton, V., Tai, A., Reuter, S., & Ward, M. (2024). Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Zealand. European Journal of Hospital Pharmacy, 31(4), 301-306.
DOI Scopus2 WoS2
2024 Alonge, M., Coller, J. K., Reuter, S. E., Jesudason, S., & Sallustio, B. C. (2024). Determining Plasma Tacrolimus Concentrations Using High-Performance LC-MS/MS in Renal Transplant Recipients.. Therapeutic drug monitoring, 46(1), 49-56.
DOI Scopus3 WoS2 Europe PMC2
2024 Wong, S., Selby, P. R., & Reuter, S. E. (2024). Determination of a vancomycin nephrotoxicity threshold and assessment of target attainment in hematology patients. Pharmacology Research & Perspectives, 12(4, article no. e1231), 1-10.
DOI Scopus2 WoS1 Europe PMC2
2024 Meola, T. R., Elz, A., Wignall, A., Paxton, K., Hunter, A., Ariaee, A., . . . Joyce, P. (2024). Inulin-Lipid Core–Shell Microcapsules Target the Gut Microbiota and Mimic the Pharmaceutical Food Effect for Improved Oral Antipsychotic Delivery. Advanced Functional Materials, 34(40), 12 pages.
DOI Scopus18 WoS15
2024 Yang, J. J., Brett, J., Sordo, A., Reuter, S. E., Stocker, S. L., Day, R. O., . . . Carland, J. E. (2024). The influence of a therapeutic drug monitoring service on vancomycin-associated nephrotoxicity. Journal of Clinical Pharmacology, 64(1), 1-11.
DOI Scopus7 WoS7 Europe PMC4
2024 Stojanova, J., Brown, J. D., Reuter, S. E., & Marriott, D. J. E. (2024). Very high linezolid clearance in a critically ill patient: a case report suggesting a novel metabolic induction mechanism. International Journal of Antimicrobial Agents, 63(6), 1-3.
DOI
2024 Evans, A. M., Fornasini, G., Meola, T. R., Gahl, W. A., Huizing, M., Polasek, T. M., & Reuter, S. E. (2024). Impact of Food on the Oral Absorption of N-Acetyl-D-Mannosamine in Healthy Men and Women. Clinical Pharmacology in Drug Development, 13(8), 876-883.
DOI Scopus3 WoS3 Europe PMC3
2023 Schultz, H. B., Hosseini, A., McLachlan, A. J., & Reuter, S. E. (2023). Population pharmacokinetics of oral-based administration of cannabidiol in healthy adults: implications for drug development. Cannabis and Cannabinoid Research, 8(5), 877-886.
DOI Scopus12 WoS10 Europe PMC10
2023 Carland, J. E., Stacy, A. E., Schaffer, A. L., Day, R. O., Brett, J., Reuter, S. E., & Stocker, S. L. (2023). Blood, dose recommendation reports and phone calls: experiences of a therapeutic drug monitoring advisory service for vancomycin. British Journal Of Clinical Pharmacology, 89(6), 1896-1902.
DOI Scopus1 WoS1
2023 Nguyen, T. A., Kirubakaran, R., Schultz, H. B., Wong, S., Reuter, S. E., McMullan, B., . . . Stocker, S. L. (2023). Analytical and non-analytical variation may lead to inappropriate antimicrobial dosing in neonates: an in silico study. Clinical Chemistry, 69(6), 637-648.
DOI Scopus2 WoS2 Europe PMC2
2023 Shafiei, M., Galettis, P., Beale, P., Reuter, S. E., Martin, J. H., McLachlan, A. J., & Blinman, P. (2023). Influence of age on pharmacokinetics of capecitabine and its metabolites in older adults with cancer: a pilot study. Cancer Chemotherapy and Pharmacology, 92(2), 135-139.
DOI Scopus2 WoS1 Europe PMC1
2023 Wong, S., Davis, A., Selby, P. R., Khoo, R., Gwilt, I., Stocker, S. L., . . . Reuter, S. E. (2023). Application of user-centered co-design principles to address barriers in therapeutic drug monitoring.. Therapeutic drug monitoring, 45(3), 368-375.
DOI Scopus4 WoS4 Europe PMC5
2023 Lau, C., Marriott, D., Bui, J., Figtree, M., Reuter, S. E., & Alffenaar, J. W. (2023). Linezolid monitoring to minimise toxicity (LIMMIT1): A multicentre retrospective review of patients receiving linezolid therapy and the impact of therapeutic drug monitoring. International Journal of Antimicrobial Agents, 61(5), 1-8.
DOI Scopus26 WoS26 Europe PMC21
2022 Seah, V., Sreeharan, T., Kocic, D., Reuter, S. E., Girgis, L., Marriott, D. J. E., & Stocker, S. L. (2022). Effect of therapeutic Plasma exchange on Itraconazole Pharmacokinetics: a case study. Therapeutic Drug Monitoring, 45(2), 129-132.
DOI Scopus1 WoS1 Europe PMC1
2022 Wong, S., Reuter, S. E., Jones, G. R. D., & Stocker, S. L. (2022). Review and evaluation of vancomycin dosing guidelines for obese individuals. Expert Opinion on Drug Metabolism and Toxicology, 18(5), 323-335.
DOI Scopus6 WoS6 Europe PMC5
2022 Reuter, S. E., Stocker, S. L., Alffenaar, J. W. C., Baldelli, S., Cattaneo, D., Jones, G., . . . Marriott, D. J. E. (2022). Optimal practice for vancomycin therapeutic drug monitoring: position statement from the anti-infectives committee of the international association of therapeutic drug monitoring and clinical toxicology. Therapeutic drug monitoring, 44(1), 121-132.
DOI Scopus49 WoS45 Europe PMC37
2022 Chughlay, M. F., Barnes, K. I., El Gaaloul, M., Abla, N., Mohrle, J. J., Griffin, P., . . . Chalon, S. (2022). Safety, tolerability, pharmacokinetics, and pharmacodynamics of coadministered ruxolitinib and artemether-lumefantrine in healthy adults. Antimicrobial Agents and Chemotherapy, 66(1, article no. e01584-21), 1-13.
DOI Scopus10 WoS10 Europe PMC10
2022 Wong, D. D., van Zuylen, W. J., Novos, T., Stocker, S., Reuter, S. E., Au, J., . . . Rawlinson, W. D. (2022). Detection of ganciclovir-resistant cytomegalovirus in a prospective cohort of kidney transplant recipients receiving subtherapeutic valganciclovir prophylaxis. Microbiology spectrum, 10(3), 1-10.
DOI Scopus19 WoS17 Europe PMC13
2021 Stocker, S. L., Carland, J. E., Reuter, S. E., Stacy, A. E., Schaffer, A. L., Stefani, M., . . . Brett, J. (2021). Evaluation of a pilot vancomycin precision dosing advisory service on target exposure attainment using an interrupted time series analysis. Clinical Pharmacology & Therapeutics, 109(1), 212-221.
DOI Scopus20 WoS20 Europe PMC16
2021 Reuter, S. E., Schultz, H. B., Ward, M. B., Grant, C. L., Paech, G. M., Banks, S., & Evans, A. M. (2021). The effect of high-dose, short-term caffeine intake on the renal clearance of calcium, sodium and creatinine in healthy adults. British Journal of Clinical Pharmacology, 87(11), 4461-4466.
DOI Scopus15 WoS13 Europe PMC14
2021 Lau, C., Marriott, D., Schultz, H. B., Gould, M., Andresen, D., Wicha, S. G., . . . Reuter, S. E. (2021). Assessment of cefepime toxicodynamics: comprehensive examination of pharmacokinetic/pharmacodynamic targets for cefepime-induced neurotoxicity and evaluation of current dosing guidelines. International Journal of Antimicrobial Agents, 58(106443), 1-7.
DOI Scopus17 WoS17 Europe PMC18
2021 Sandaradura, I., Marriott, D. J. E., Day, R. O., Norris, R. L. G., Pang, E., Stocker, S. L., & Reuter, S. E. (2021). Current fluconazole treatment regimens result in under-dosing of critically ill adults during early therapy. European Journal Of Clinical Microbiology & Infectious Diseases, 40(7), 1521-1528.
DOI Scopus13 WoS14 Europe PMC10
2021 Sandaradura, I., Wojciechowski, J., Marriott, D. J. E., Day, R. O., Stocker, S., & Reuter, S. E. (2021). Model-optimized fluconazole dose selection for critically ill patients improves early pharmacodynamic target attainment without the need for therapeutic drug monitoring. Antimicrobial Agents and Chemotherapy, 65(3), 1-10.
DOI Scopus9 WoS8 Europe PMC4
2021 Roydhouse, S. A., Carland, J. E., Debono, D. S., Baysari, M. T., Reuter, S. E., Staciwa, A. J., . . . Stocker, S. L. (2021). Accuracy of documented administration times for intravenous antimicrobial drugs and impact on dosing decisions. British Journal of Clinical Pharmacology, 87(11), 4273-4282.
DOI Scopus17 WoS16 Europe PMC14
2021 Menz, B. D., Stocker, S. L., Verougstraete, N., Kocic, D., Galettis, P., Stove, C. P., & Reuter, S. E. (2021). Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncology. British Journal of Clinical Pharmacology, 87(2), 227-236.
DOI Scopus44 WoS39 Europe PMC33
2020 Harris, B. D. W., Phan, V., Perera, V., Szyc, A., Galettis, P., Martin, J. H., . . . Charles, K. A. (2020). Inability of current dosing to achieve carboplatin therapeutic targets in people with advanced non-small cell lung cancer: impact of systemic inflammation on carboplatin exposure and clinical outcomes. Clinical Pharmacokinetics, 59(8), 1013-1026.
DOI Scopus4 WoS4 Europe PMC3
2020 Lau, C., Marriott, D., Gould, M., Andresen, D., Reuter, S. E., & Penm, J. (2020). A retrospective study to determine the cefepime-induced neurotoxicity threshold in hospitalized patients. The Journal of antimicrobial chemotherapy, 75(3), 718-725.
DOI Scopus46 WoS46 Europe PMC43
2020 Teng, C., Reuter, S. E., Blinman, P. L., Dhillon, H. M., Galettis, P., Proschogo, N., . . . Vardy, J. L. (2020). Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: a pilot study assessing preliminary efficacy, tolerability and pharmacokinetic interactions in patients with metastatic gastrointestinal cancer. Cancer Chemotherapy and Pharmacology, 86(4), 547-558.
DOI Scopus5 WoS7 Europe PMC6
2020 Shingde, R. V., Reuter, S. E., Graham, G. G., Carland, J. E., Williams, K. M., Day, R. O., & Stocker, S. L. (2020). Assessing the accuracy of two Bayesian forecasting programs in estimating vancomycin drug exposure. Journal of Antimicrobial Chemotherapy, 75(11), 3239-3302.
DOI Scopus27 WoS27 Europe PMC23
2019 Reuter, S. E., Evans, A. M., & Ward, M. B. (2019). Reducing palivizumab dose requirements through rational dose regimen design. CPT: pharmacometrics and systems pharmacology, 8(1), 26-33.
DOI Scopus3 WoS4 Europe PMC6
2019 Shingde, R. V., Graham, G. G., Reuter, S. E., Carland, J. E., Day, R. O., & Stocker, S. L. (2019). Comparison of the area under the curve for vancomycin estimated using compartmental and noncompartmental methods in adult patients with normal renal function. Therapeutic drug monitoring, 41(6), 726-731.
DOI Scopus18 WoS16
2019 Hughes, J. H., Phelps, M. A., Upton, R. N., Reuter Lange, S. E., Gao, Y., Byrd, J. C., . . . Foster, D. J. R. (2019). Population pharmacokinetics of lenalidomide in patients with B-cell malignancies. British journal of clinical pharmacology, 85(5), 924-934.
DOI Scopus13 WoS11 Europe PMC13
2019 Hughes, J. H., Upton, R. N., Reuter, S. E., Phelps, M. A., & Foster, D. J. R. (2019). Optimising time samples for determining area under the curve of pharmacokinetic data using non-compartmental analysis. Journal of pharmacy and pharmacology, 71(11), 1635-1644.
DOI Scopus10 WoS11 Europe PMC9
2019 Hughes, J. H., Upton, R. N., Reuter, S. E., Rozewski, D. M., Phelps, M. A., & Foster, D. J. R. (2019). Development of a physiologically based pharmacokinetic model for intravenous lenalidomide in mice. Cancer Chemotherapy and Pharmacology, 84(5), 1073-1087.
DOI Scopus8 WoS8 Europe PMC8
2019 Milliken, E., de Zwart, A. E. S., Alffenaar, J. W. C., Marriott, D. J. E., Riezebos Brilman, A., Schteinman, A., . . . Reuter, S. E. (2019). Population pharmacokinetics of ribavirin in lung transplant recipients and examination of current and alternative dosing regimens. Journal of antimicrobial chemotherapy, 74(3), 691-698.
DOI Scopus4 WoS4 Europe PMC4
2018 Lucas, C. J., Galettis, P., Song, S., Solowij, N., Reuter, S. E., Schneider, J., & Martin, J. H. (2018). Cannabinoid disposition after human intraperitoneal use: an insight into intraperitoneal pharmacokinetic properties in metastatic cancer. Clinical therapeutics, 40(9), 1442-1447.
DOI Scopus14 WoS12 Europe PMC9
2017 Hughes, J. H., Reuter, S. E., Upton, R. N., Phelps, M., & Foster, D. J. R. (2017). Population pharmacokinetics of lenalidomide in patients with haematological cancer. Journal of Pharmacokinetics and Pharmacodynamics, 44(S1), 72.
2016 Reuter, S. E., & Martin, J. H. (2016). Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome. Clinical Pharmacokinetics, 55(7), 807-812.
DOI Scopus40 WoS36 Europe PMC31
2016 Ward, M. B., Reuter, S. E., & Martin, J. H. (2016). How 'optimal' are optimal sampling times for tyrosine kinase inhibitors in cancer? Practical considerations. Clinical pharmacokinetics, 55(10), 1171-1177.
DOI Scopus6 WoS5 Europe PMC3
2015 Reuter, S., Evans, A., Shakib, S., Lungershausen, Y., Francis, B., Valentini, G., . . . Pace, S. (2015). Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin. Clinical Drug Investigation, 35(9), 559-567.
DOI Scopus27 WoS26 Europe PMC25
2014 Reuter, S., Upton, R., Evans, A., Navaratnam, V., & Olliaro, P. (2014). Population pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria. Journal of Antimicrobial Chemotherapy, 70(3), 868-876.
DOI Scopus17 WoS17 Europe PMC15
2014 Fooladi, E., Reuter, S. E., Bell, R. J., Robinson, P. J., & Davis, S. R. (2014). Pharmacokinetics of a transdermal testosterone cream in healthy postmenopausal women. Menopause: the journal of the North American Menopause Society, 20(1), 44-49.
DOI Scopus24 WoS20 Europe PMC16
2013 Reuter, S., & Evans, A. (2013). What is the value of l-carnitine level determination for carnitine supplementation in hemodialysis patients?. Hemodialysis International, 17(3), 335-338.
DOI Scopus1 WoS1 Europe PMC1
2012 Reuter, S. E., & Evans, A. M. (2012). Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects. Clinical pharmacokinetics, 51(9), 553-572.
DOI WoS405
2012 Wiese, M., Sluggett, J., Wilson, C., Reuter, S., Turner, S., & Evans, A. (2012). Perceived and actual paracetamol dosing in overweight and obese children. EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 19(5), 438-442.
DOI Scopus2 WoS2
2012 Reuter, S. E., & Evans, A. M. (2012). Carnitine and acylcarnitines: Pharmacokinetic, pharmacological and clinical aspects. Clinical Pharmacokinetics, 51(9), 553-572.
DOI Scopus423 Europe PMC359
2011 Reuter, L. S. E., Massy Westropp, N. M., & Evans, A. M. (2011). Reliability and validity of indices of hand-grip strength and endurance. Australian occupational therapy journal, 58(2), 82-87.
DOI Scopus60 WoS55 Europe PMC46
2011 Reuter, S. E., & Evans, A. M. (2011). Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity. Journal of internal medicine, 270(1), 76-84.
DOI Scopus42 WoS37 Europe PMC34
2010 Olliaro, P., Ramanathan, S., Vaillant, M., Reuter, L. S. E., Evans, A. M., Krudsood, S., . . . Navaratnam, V. (2010). Pharmacokinetics and comparative bioavailability of artesunate and mefloquine administered separately or as a fixed combination product to healthy volunteers and patients with uncomplicated plasmodium falciparum malaria. Journal of bioequivalence and bioavailability, 2(3), 59-66.
DOI
2009 Reuter, S., Faull, R., Ranieri, E., & Evans, A. (2009). Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients. Nephrology Dialysis Transplantation, 24(3), 990-996.
DOI Scopus35 WoS33 Europe PMC26
2008 Reuter, S., Faull, R., & Evans, A. (2008). L-carnitine supplementation in the dialysis population: Are Australian patients missing out?. Nephrology, 13(1), 3-16.
DOI Scopus29 WoS29 Europe PMC18
2008 Reuter, L. S. E., Evans, A. M., Chace, D., & Fornasini, G. (2008). Determination of the reference range of endogenous plasma carnitines in healthy adults. Annals of Clinical Biochemistry, 45(6), 585-592.
DOI Scopus53 WoS51 Europe PMC37
2005 Reuter, S., Evans, A., Faull, R., Chace, D., & Fornasini, G. (2005). Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease. Annals of Clinical Biochemistry, 42(PN Part 5), 387-393.
DOI Scopus33 WoS30 Europe PMC22
2005 Reuter, S. E., Evans, A. M., & Fornasini, G. (2005). Reply from the Authors [2]. Kidney International, 68(3), 1368-1369.
DOI
2005 Reuter, S. E., Evans, A. M., & Fornasini, G. (2005). Changes in the composition of carnitines in hemodialysis patients - Reply. KIDNEY INTERNATIONAL, 68(3), 1368-1369.
2004 Evans, A. M., Faull, R., Nation, R., Prasad, S., Elias, T., Reuter Lange, S. E., & Fornasini, G. (2004). Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease. Kidney International, 66(4), 1527-1534.
DOI Scopus63 WoS52 Europe PMC41

Year Citation
2024 Brungs, D., Hill, J., Aghmesheh, M., Ackland, S. P., Parker, S., Jokela, R. M., . . . Clingan, P. R. (2024). A phase I dose-escalation study of an all-in-one 5-fluorouracil and leucovorin co-formulation administered after failure of standard treatment. In Journal of Clinical Oncology Vol. 42 (pp. 1 page). IL, Chicago: LIPPINCOTT WILLIAMS & WILKINS.
DOI
2021 Shafiei, M., Galettis, P., Beale, P., Reuter, S., Martin, J., McLachlan, A., & Blinman, P. (2021). Influence of age on pharmacokinetics of capecitabine and its metabolites in older adults with cancer: A prospective observational study. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 17 (pp. 111). WILEY.
2019 Shingde, R., Graham, G., Reuter, S., Carland, J., Williams, K., Day, R., & Stocker, S. (2019). PREDICTIVE PERFORMANCE OF A COMMERCIAL BAYESIAN FORECASTING PROGRAM IN ESTIMATING VANCOMYCIN DRUG EXPOSURE.. In CLINICAL PHARMACOLOGY & THERAPEUTICS Vol. 105 (pp. S38). DC, Washington: WILEY.
2018 Centofanti, S. A., Dorrian, J., Grant, C., Stepien, J., Coates, A., Lushington, K., . . . Banks, S. (2018). THE EFFECTIVENESS OF CAFFEINE GUM IN REDUCING SLEEP INERTIA FOLLOWING A 30MIN NIGHTTIME NAP OPPORTUNITY: PRELIMINARY RESULTS. In SLEEP Vol. 41 (pp. A78). MD, Baltimore: OXFORD UNIV PRESS INC.
DOI WoS4
2016 Milliken, E., Lange, S. R., Marriott, D., Schteinman, A., Sandaradura, I., Carlos, L., . . . Glanville, A. (2016). A predictive pharmacokinetic model of ribavirin plasma concentration in lung transplant recipients with active respiratory syncytial virus or human metapneumovirus infection. In TRANSPLANTATION Vol. 100 (pp. S757). LIPPINCOTT WILLIAMS & WILKINS.

Year Citation
2024 Nitschke, S., Meola, T., Wiese, M., & Reuter Lange, S. (2024). Validation of an analytical method for the determination of leucovorin (FTHF) and methyltetrahydrofolate (MeTHF) in human plasma by LC-MS/MS. Australia: UniSA Clinical and Health Sciences, University of South Australia.
2024 Nitschke, S., Meola, T., Wiese, M., & Reuter Lange, S. (2024). Validation of two analytical methods (ALM-005 and ALM-006) for the determination of 6S-methyltetrahydrofolate (6S-MeTHF) and 6R-methyltetrahydrofolate (6R-MeTHF) in human plasma by LC-MS/MS. Australia: UniSA Clinical and Health Sciences, University of South Australia.
2024 Nitschke, S., Meola, T., Wiese, M., & Reuter Lange, S. (2024). Validation of two analytical methods (ALM-003 and ALM-004) for the determination of levoleucovorin (6S-FTHF) and 6R-leucovorin (6R-FTHF) in human plasma by LC-MS/MS. Australia: UniSA Clinical and Health Sciences, University of South Australia.
2024 Nitschke, S., Meola, T., Wiese, M., & Reuter Lange, S. (2024). Validation of an analytical method for the determination of 5 fluorouracil (5FU) and dihydrofluorouracil (DHFU) in human plasma by LC-MS/MS. Australia: UniSA Clinical and Health Sciences, University of South Australia.
2021 Ward, M., Reuter Lange, S., & Staff, K. (2021). International biosimilar medicines catalogue and summary of published literature: quarterly update October-December 2020. Australia: GBMA Education.
2020 Ward, M., Reuter Lange, S., & Staff, K. (2020). International biosimilar medicines review of the literature: quarterly update: quarterly update July-September 2020. Australia: GBMA Education.
2020 Ward, M., Reuter Lange, S., & Staff, K. (2020). International biosimilar medicines review of the literature: quarterly update January 2020 - March 2020. Australia: GBMA Education.
2020 Ward, M., Reuter Lange, S., & Staff, K. (2020). International biosimilar medicines review of the literature: quarterly update October 2019 - December 2019. Australia: GBMA Education.
2020 Ward, M., Reuter Lange, S., & Staff, K. (2020). International biosimilar medicines: catalogue and summary of published literature: quarterly update April 2020 - June 2020. Australia: GBMA Education, Australia.
2019 Ward, M., Reuter Lange, S., & Staff, K. (2019). International biosimilar medicines review of the literature: quarterly update July 2019 - September 2019. Australia: GBMA Education.
2019 Ward, M., Reuter Lange, S., & Staff, K. (2019). International biosimilar medicines review of the literature: quarterly update April 2019 - June 2019. Australia: GBMA Education.
2019 Ward, M., Reuter Lange, S., & Staff, K. (2019). International biosimilar medicines review of the literature: quarterly update January 2019 - March 2019. Australia: GBMA Education.
2019 Ward, M., Reuter Lange, S., & Staff, K. (2019). International biosimilar medicines review of the literature: quarterly update June 2018 - September 2018. Australia: GBMA Education.
2018 Ward, M., Reuter Lange, S., & Staff, K. (2018). International biosimilar medicines review of the literature: quarterly update October 2018 - December 2018. Australia: GBMA Education.
2018 Ward, M., Reuter Lange, S., & Staff, K. (2018). Literature review of international biosimilar medicines: update December 2017 - February 2018. Australia: Commonwealth of Australia as represented by the Department of Health.
2018 Ward, M., Reuter Lange, S., & Staff, K. (2018). Literature review of international biosimilar medicines: update March - May 2018. Australia: Commonwealth of Australia as represented by the Department of Health.
2017 Ward, M., Reuter Lange, S., & Staff, K. (2017). Literature review of international biosimilar medicines: update March - May 2017. Australia: Commonwealth of Australia as represented by the Department of Health.
2017 Ward, M., Reuter Lange, S., & Staff, K. (2017). Literature review of international biosimilar medicines: update September - November 2017. Australia: Commonwealth of Australia as represented by the Department of Health.
2017 Ward, M., Reuter Lange, S., & Staff, K. (2017). Literature review of international biosimilar medicines: update December 2016 - March 2017. Australia: Commonwealth of Australia as represented by the Department of Health.
2017 Ward, M., Reuter Lange, S., & Staff, K. (2017). Literature review of international biosimilar medicines: update June - August 2017. Australia: Commonwealth of Australia as represented by the Department of Health.
2016 Ward, M., Reuter Lange, S., & Staff, K. (2016). Literature review of international biosimilar medicines: update September - December 2016. Australia: Commonwealth of Australia as represented by the Department of Health.
2016 Ward, M., Reuter Lange, S., & Staff, K. (2016). Literature review of International Biosimilar Medicines: Update June - September 2016. Australia: Commonwealth of Australia as represented by the Department of Health.
2016 Ward, M., Reuter Lange, S., & Staff, K. (2016). Literature review of international biosimilar medicines. Australia: Commonwealth of Australia as represented by the Department of Health.

  • PPK Research Services under Panel arrangement, Therapeutic Goods Administration, 16/04/2025 - 15/05/2028

  • McCloud | Pharmacokinetic Analysis & Reporting, McCloud Consulting Group Pty Ltd, 01/05/2025 - 30/04/2028

  • Development of ResectAssist: a drug-eluting implantable device for the localised treatment for pancreatic cancer, Australia's Economic Accelerator Ignite Grant, 04/09/2025 - 25/12/2026

  • Neoculi | Pharmacokinetic Analysis & Reporting - A GSP pharmacokinetic study in dogs comparing two investigational
veterinary products administered via the intravenous and oral routes, Neoculi Pty Ltd, 28/08/2023 - 27/08/2026

  • Development of a chemotherapy-loaded implantable device for the localised treatment of inoperable pancreatic cancer, Tour de Cure Ltd, 01/03/2024 - 30/08/2025

  • Optimising Cancer Therapy through Development of Evidence-Based Dose Individualisation Strategies, Cancer Council SA Research Fellowship, 01/07/2020 - 30/06/2023

  • The buccal administration of a Cannabis sativa L./Cannabis indica L. extract as an adjunct to opioid analgesia for the management of intractable pain in patients diagnosed with advanced cancer., Medlab Clinical Ltd, 01/07/2020 - 30/06/2022

  • PK analysis research services for clinical study DTX-SPL8783, Starpharma, 04/07/2016 - 30/12/2020

  • PK & PD biostatistical studies, TetraQ, 09/10/2014 - 31/12/2019

  • Literature Review of International Biosimilar Medicines, Cwth Dept of Health Aged Care, 01/03/2016 - 30/06/2018

  • PK and PD research advice, Prana Biotechnology, 25/09/2014 - 31/12/2017

  • Improving the therapeutic use of anti-infective agents: Application of pharmacometrics for rational dosing regimen design, NHMRC - Early Career Fellowship, 13/05/2013 - 12/05/2017

Courses I teach

  • PHAR 2021 Pharmacology B (2025)
  • PHAR 2024 Clinical Trials for Drug Development (2025)
  • PHAR 2021 Pharmacology B (2024)
  • PHAR 2024 Clinical Trials for Drug Development (2024)

Date Role Research Topic Program Degree Type Student Load Student Name
2025 Principal Supervisor Evaluation of a digital clinical decision support system to support clinical translation of precision medicine Doctor of Philosophy Doctorate Full Time Mr Aaron Matthew Kinnear
2025 Co-Supervisor Investigating Gut Microbial Hydrogen Sulphide (H2S) as a Biomarker and Therapeutic Target for Ulcerative Colitis - Doctorate Full Time Miss Kate Collins
2024 Principal Supervisor Implementation and evaluation of optimal dose individualization for vancomycin in paediatric patients - Doctorate Part Time Mr Brett Ritchie
2023 Principal Supervisor Pharmacogenomics to achieve precision dosing of fluoropyrimidines (FP) in cancer patients Doctor of Philosophy Doctorate Part Time Miss Deirdre Landsberg
2022 Principal Supervisor Optimising treatment of haematological malignancies through the development of evidence-based dose individualisation strategies Doctor of Philosophy Doctorate Part Time Mr Elias Constantinos Biris
2018 Co-Supervisor Validate and optimization of Aminoglycoside Therapeutic Drug Monitoring in children and adults. - Doctorate Part Time Ms Rebecca Larcombe

Date Role Committee Institution Country
2020 - ongoing Member Anti-Infectives Committee International Association of Therapeutic Drug Monitoring and Clinical Toxicology Italy
2018 - 2020 Member Steering Committee, Personalised and Precision Medicine International Pharmaceutical Federation Netherlands
2017 - 2020 Board Member Board of Pharmaceutical Sciences International Pharmaceutical Federation Netherlands
2017 - 2020 President Executive Committee Australasian Pharmaceutical Science Association Australia
2009 - 2016 Secretary Executive Committee Australasian Pharmaceutical Science Association Australia
2008 - 2023 Member Executive Committee Australasian Pharmaceutical Science Association Australia

Date Role Editorial Board Name Institution Country
2020 - 2025 Editor British Journal of Clinical Pharmacology British Pharmacological Society United Kingdom

Date Title Type Institution Country
2025 - ongoing ESF College of Experts - European Science Foundation France
2025 - ongoing Deputy Chair - Bellberry Human Research Ethics Committee Australia
2022 - ongoing Expert Advisor - Therapeutic Goods Administration Australia
2008 - ongoing Scientific Expert - Bellberry Human Research Ethics Committee Australia

Connect With Me

External Profiles

Other Links